Role of spinal muscarinic and nicotinic receptors in clonidine-induced nitric oxide release in a rat model of neuropathic pain

Brain Research

Volumn 861, Issue 2, 2000, Pages 390-398

  Xu, Zemin ^a   Chen, Shao Rui ^a   C Eisenach, James ^a   Pan, Hui Lin ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

2 Adrenergic receptor; Acetylcholine; Cholinergic receptor; Neuropathic pain; Nitric oxide synthase

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ATROPINE; CLONIDINE; HEXAMETHONIUM; IDAZOXAN; MECAMYLAMINE; MUSCARINIC RECEPTOR; NICOTINIC RECEPTOR; NITRIC OXIDE; NITRITE; SCOPOLAMINE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; MALE; NERVE INJURY; NEURALGIA; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; CLONIDINE; MALE; MUSCARINIC ANTAGONISTS; NICOTINIC ANTAGONISTS; NITRIC OXIDE; NITRITES; PAIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, MUSCARINIC; SPINAL CORD; SPINAL NERVES;

EID: 0034646956     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02051-5     Document Type: Article

References (38)

1. Adams C.E., Freedman R. Nicotinic antagonist, alpha-bungarotoxin, binding to rat hippocampal neurons containing nitric oxide synthase. Brain Res. 776:1997;111-116.
2. Arner S., Meyerson B.A. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain. 33:1988;11-23.
3. Ayajiki K., Okamura T., Toda N. Neurogenic relaxations caused by nicotine in isolated cat middle cerebral arteries. J. Pharmacol. Exp. Ther. 270:1994;795-801.
4. Bannon A.W., Decker M.W., Holladay M.W., Curzon P., Donnelly-Roberts D., Puttfarcken P.S., Bitner R.S., Diaz A., Dickenson A.H., Porsolt R.D., Williams M., Arneric S.P. Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science. 279:1998;77-81.
5. De Kock M., Eisenach J., Tong C., Schmitz A.L., Scholtes J.L. Analgesic doses of intrathecal but not intravenous clonidine increase acetylcholine in cerebrospinal fluid in humans. Anesth. Analg. 84:1997;800-803.
6. 2 adrenoceptor-mediated antinociception in sheep. J. Pharmacol. Exp. Ther. 265:1993;536-542.
7. El-Dada M.D., Quik M. Involvement of nitric oxide in nicotinic receptor-mediated myopathy. J. Pharmacol. Exp. Ther. 281:1997;1463-1470.
8. 4 receptor subtype. J. Pharmacol. Exp. Ther. 288:1999;1143-1150.
9. 3H ]acetylcholine binding sites in the cervical spinal cord of man and some other species Neurosci. Lett. 90:1988;197-202.
10. Gordh T. Jr., Jansson I., Hartvig P.G., Gillberg C. Post-interactions between noradrenergic and cholinergic mechanisms involved in spinal nociceptive processing. Acta Anesthesiol. Scand. 33:1989;39-47.
11. Gordh T. Jr., Sharma H.S., Alm P., Westman J. Spinal nerve lesion induces upregulation of neuronal nitric oxide synthase in the spinal cord. An immunohistochemical investigation in the rat. Amino Acids. 14:1998;105-112.
12. 1, muscarinic receptor subtypes are present in rat spinal cord. J. Pharmacol. Exp. Ther. 281:1997;470-477.
13. Hwang J.H., Hwang K.S., Leem J.K., Park P.H., Han S.M., Lee D.M. The antiallodynic effects of intrathecal cholinesterase inhibitors in a rat model of neuropathic pain. Anesthesiology. 90:1999;492-499.
14. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 50:1993;355-363.
15. Klimscha W., Tong C., Eisenach J.C. Intrathecal alpha 2-adrenergic agonists stimulate acetylcholine and norepinephrine release from the spinal cord dorsal horn in sheep. An in vivo microdialysis study. Anesthesiology. 87:1997;110-116.
16. Kolesnikov Y.A., Pan Y.X., Babey A.M., Jain S., Wilson R., Pasternak G.W. Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance. Proc. Natl. Acad. Sci. USA. 94:1997;8220-8225.
17. 2 adrenergic interactions in analgesia and hemodynamic control: role of muscarinic receptor subtypes and nitric oxide. J. Pharmacol. Exp. Ther. 270:1994;1301-1306.
18. Luo Z.D., Chaplan S.R., Scott B.P., Cizkova D., Calcutt N.A., Yaksh T.L. Neuronal nitric oxide synthase mRNA upregulation in rat sensory neurons after spinal nerve ligation: lack of a role in allodynia development. J. Neurosci. 19:1999;9201-9208.
19. MacFarlane B.V., Wright A., O'Callaghan J., Benson H.A. Chronic neuropathic pain and its control by drugs. Pharmacol. Ther. 75:1997;1-19.
20. Miles A.M., Wink D.A., Cook J.C., Grisham M.B. Determination of nitric oxide using fluorescence spectroscopy. Methods Enzymol. 268:1996;105-120.
21. Moro V., Badaut J., Springhetti V., Edvinsson L., Seylaz J., Lasbennes F. Regional study of the colocalization of neuronal nitric oxide synthase with muscarinic receptors in the rat cerebral cortex. Neuroscience. 69:1995;797-805.
22. Naguib M., Yaksh T.L. Characterization of muscarinic receptor subtypes that mediate antinociception in the rat spinal cord. Anesth. Analg. 85:1997;847-885.
23. Naguib M., Yaksh T.L. Antinociceptive effects of spinal cholinesterase inhibition and isobolographic analysis of the interaction with mu and alpha 2 receptor system. Anesthesiology. 80:1994;1338-1348.
24. Nakamura K., Takahashi T., Taniuchi M., Hsu C.X., Owyang C. Nicotinic receptor mediates nitric oxide synthase expression in the rat gastric myenteric plexus. J. Clin. Invest. 101:1998;1479-1489.
25. Ossipov M.H., Lopez Y., Bian D., Nichols M.L., Porreca F. Synergistic antinociceptive interactions of morphine and clonidine in rats with nerve ligation injury. Anesthesiology. 86:1997;196-204.
26. Pan H.-L., Chen S.R., Eisenach J.C. Role of spinal nitric oxide in antiallodynic effect of intrathecal clonidine in neuropathic rats. Anesthesiology. 89:1998;1518-1523.
27. Pan H.-L., Chen S.R., Eisenach J.C. Intrathecal clonidine alleviates allodynia in neuropathic rats: Interaction with spinal muscarinic and nicotinic receptors. Anesthesiology. 90:1999;509-514.
28. Rauck R.L., Eisenach J.C., Jackson K., Young L.D., Southern J. Epidural clonidine treatment for refractory reflex sympathetic dystrophy. Anesthesiology. 79:1993;1163-1169.
29. Salter M., Duffy C., Garthwaite J., Strijbos P.J. Ex vivo measurement of brain tissue nitrite and nitrate accurately reflects nitric oxide synthase activity in vivo. J. Neurochem. 66:1996;1683-1690.
30. 1 activity: SAR of alkylthio-TZTP's and related 1,2,5-thiadiazole analogs. Life Sci. 56:1995;807-814.
31. Shannon H.E., Womer D.E., Bymaster F.P., Calligaro D.O., DeLapp N.C., Mitch C.H., Ward J.S., Whitesitt C.A., Swedberg M.D., Sheardown M.J., Fink-Jensen A., Olesen P.H., Rimvall K., Sauerberg P. In vivo pharmacology of butylthio[2.2.2] (LY297802/NNC11-1053), an orally acting antinociceptive muscarinic agonist. Life Sci. 60:1997;969-976.
32. Smith D.A., Hoffmann A.F., David D.J., Adams C.E., Gerhardt G.A. Nicotine-evoked nitric oxide release in the rat hippocampal slice. Neurosci. Lett. 255:1998;127-130.
33. Song H.K., Pan H.-L., Eisenach J.C. Spinal nitric oxide mediates antinociception from IV morphine. Anesthesiology. 89:1998;215-221.
34. Suemaru K., Kawasaki H., Gomita Y., Tanizaki Y. Involvement of nitric oxide in development of tail-tremor induced by repeated nicotine administration in rats. Eur. J. Pharmacol. 335:1997;139-143.
35. Unnerstall J.R., Kopajtic T.A., Kuhar M.J. Distribution of alpha 2 agonist binding sites in the rat and human central nervous system: analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents. Brain Res. 319:1984;69-101.
36. Wang Y., Okamura T., Toda N. Mechanisms of acetylcholine-induced relaxation in dog external and internal ophthalmic arteries. Exp. Eye Res. 57:1993;275-281.
37. Xu Z., Tong C., Pan H.-L., Cerda S.E., Eisenach J.C. Intravenous morphine increases release of nitric oxide from spinal cord by α adrenergic and cholinergic mechanism. J. Neurophysiol. 78:1997;2072-2078.
38. Yaksh T.L., Pogrel J.W., Lee Y.W., Chaplan S.R. Reversal of nerve ligation-induced allodynia by spinal alpha-2 adrenoceptor agonists. J. Pharmacol. Exp. Ther. 272:1995;207-214.